PL3065732T3 - Związki, kompozycje i odpowiednie zastosowania do zapobiegania i/lub leczenia dyslipidemii - Google Patents
Związki, kompozycje i odpowiednie zastosowania do zapobiegania i/lub leczenia dyslipidemiiInfo
- Publication number
- PL3065732T3 PL3065732T3 PL14781242T PL14781242T PL3065732T3 PL 3065732 T3 PL3065732 T3 PL 3065732T3 PL 14781242 T PL14781242 T PL 14781242T PL 14781242 T PL14781242 T PL 14781242T PL 3065732 T3 PL3065732 T3 PL 3065732T3
- Authority
- PL
- Poland
- Prior art keywords
- dyslipidemia
- prevention
- compositions
- compounds
- treatment
- Prior art date
Links
- 208000032928 Dyslipidaemia Diseases 0.000 title 1
- 208000017170 Lipid metabolism disease Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Polymers & Plastics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1302334A FR3011467B1 (fr) | 2013-10-08 | 2013-10-08 | Composes et compositions comprenant de tels composes pour la prevention ou le traitement des dyslipidemies |
| PCT/EP2014/071543 WO2015052237A1 (fr) | 2013-10-08 | 2014-10-08 | Composes, compositions et utilisations correspondantes, pour la prevention et/ou le traitement des dyslipidemies |
| EP14781242.4A EP3065732B1 (fr) | 2013-10-08 | 2014-10-08 | Composes, compositions et utilisations correspondantes, pour la prevention et/ou le traitement des dyslipidemies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3065732T3 true PL3065732T3 (pl) | 2019-03-29 |
Family
ID=50023610
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14781242T PL3065732T3 (pl) | 2013-10-08 | 2014-10-08 | Związki, kompozycje i odpowiednie zastosowania do zapobiegania i/lub leczenia dyslipidemii |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US9821000B2 (pl) |
| EP (2) | EP3065732B1 (pl) |
| JP (2) | JP6502335B2 (pl) |
| CN (2) | CN105828814B (pl) |
| AU (2) | AU2014333853A1 (pl) |
| BR (1) | BR112016007536B1 (pl) |
| CA (2) | CA2926582C (pl) |
| ES (2) | ES2674869T3 (pl) |
| FR (1) | FR3011467B1 (pl) |
| PL (1) | PL3065732T3 (pl) |
| WO (2) | WO2015052433A1 (pl) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2635581C (en) | 2005-12-28 | 2017-02-28 | Vertex Pharmaceuticals Incorporated | Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| US9744542B2 (en) | 2013-07-29 | 2017-08-29 | Apeel Technology, Inc. | Agricultural skin grafting |
| FR3011467B1 (fr) * | 2013-10-08 | 2016-02-12 | Centre Nat Rech Scient | Composes et compositions comprenant de tels composes pour la prevention ou le traitement des dyslipidemies |
| RU2749213C2 (ru) | 2014-10-07 | 2021-06-07 | Вертекс Фармасьютикалз Инкорпорейтед | Сокристаллы модуляторов регулятора трансмембранной проводимости при кистозном фиброзе |
| WO2016187581A1 (en) | 2015-05-20 | 2016-11-24 | Apeel Technology, Inc. | Plant extract compositions and methods of preparation thereof |
| CN108135188B (zh) | 2015-09-16 | 2022-08-05 | 阿比尔技术公司 | 用于分子涂层的前体化合物 |
| EP3386303B1 (en) | 2015-12-10 | 2020-03-11 | Apeel Technology, Inc. | Process for depolymerising cutin |
| TWI731928B (zh) | 2016-01-26 | 2021-07-01 | 美商ａＰＥＥＬ科技公司 | 製備及保存經消毒產品之方法 |
| EP3541192B1 (en) | 2016-11-17 | 2025-06-25 | Apeel Technology, Inc. | Methods of preparing fatty acid esters from crosslinked polyesters |
| US12245605B2 (en) | 2018-09-05 | 2025-03-11 | Apeel Technology, Inc. | Compounds and formulations for protective coatings |
| EP3955913A4 (en) * | 2019-04-16 | 2023-01-04 | Enzychem Lifesciences | Compositions and methods for treating diabetes |
| KR102218540B1 (ko) * | 2019-04-16 | 2021-02-22 | 주식회사 엔지켐생명과학 | 모노아세틸디아실글리세롤 화합물을 함유하는 당뇨병 치료용 조성물 및 당뇨병의 치료 방법 |
| US11641865B2 (en) | 2020-03-04 | 2023-05-09 | Apeel Technology, Inc. | Compounds and formulations for protective coatings |
| EP4237400A1 (en) | 2020-10-30 | 2023-09-06 | Apeel Technology, Inc. | Compositions and methods of preparation thereof |
| CN118159138A (zh) | 2021-09-08 | 2024-06-07 | 阿比尔技术公司 | 用于保护性涂层的化合物和制剂 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5914520B2 (ja) * | 1977-07-29 | 1984-04-04 | カネボウ株式会社 | 二層型液状シヤンプ− |
| JPS5953421A (ja) * | 1983-02-15 | 1984-03-28 | Ajinomoto Co Inc | コレステロ−ル低下または上昇抑制剤 |
| EP0104043A3 (en) * | 1982-09-20 | 1984-06-06 | Ajinomoto Co., Inc. | Foodstuffs and pharmaceuticals |
| AU773778B2 (en) * | 1999-09-08 | 2004-06-03 | Watson Pharmaceuticals, Inc. | Using quaternary ammonium salts for transdermal drug delivery |
| ATE330575T1 (de) * | 2000-04-03 | 2006-07-15 | 3M Innovative Properties Co | Dentalmaterialien mit verlängerter verarbeitungszeit, kits und verfahren |
| IL142537A0 (en) * | 2001-04-11 | 2002-03-10 | Yeda Res & Dev | Pharmaceutical compositions for the treatment of autoimmune diseases |
| WO2003040354A1 (en) * | 2001-07-09 | 2003-05-15 | Alexion Pharmaceuticals, Inc. | Capacitative calcium entry mechanism in porcine oocytes |
| WO2003043054A2 (en) * | 2001-11-15 | 2003-05-22 | Koninklijke Philips Electronics N.V. | High-pressure discharge lamp |
| US7700583B2 (en) * | 2003-04-11 | 2010-04-20 | High Point Pharmaceuticals, Llc | 11β-hydroxysteroid dehydrogenase type 1 active compounds |
| GB0425658D0 (en) * | 2004-11-22 | 2004-12-22 | Stanford Rook Ltd | Immunotherapeutic agent |
| US20090124608A1 (en) * | 2006-10-16 | 2009-05-14 | Board Of Trustees Of The University Of Arkansas | CB2 Receptor Modulators In Neurodegenerative Diseases And Applications Of The Same |
| EP2445494A4 (en) * | 2009-06-24 | 2012-12-12 | Univ Koebenhavn | TREATMENT OF INSULIN RESISTANCE AND OBESITY BY STIMULATING GLP-1 RELEASE |
| EP2629773A2 (en) * | 2010-10-19 | 2013-08-28 | Elcelyx Therapeutics, Inc. | Chemosensory receptor ligand-based therapies |
| RU2642631C2 (ru) * | 2013-08-19 | 2018-01-25 | Энзикем Лайфсайенсиз Корпорейшн | Композиция для предотвращения или лечения хронических обструктивных заболеваний легких, содержащая моноацетилдиглицерольные соединения в качестве активного ингредиента |
| FR3011467B1 (fr) * | 2013-10-08 | 2016-02-12 | Centre Nat Rech Scient | Composes et compositions comprenant de tels composes pour la prevention ou le traitement des dyslipidemies |
-
2013
- 2013-10-08 FR FR1302334A patent/FR3011467B1/fr active Active
-
2014
- 2014-10-08 WO PCT/FR2014/052546 patent/WO2015052433A1/fr not_active Ceased
- 2014-10-08 CN CN201480055571.3A patent/CN105828814B/zh active Active
- 2014-10-08 AU AU2014333853A patent/AU2014333853A1/en not_active Abandoned
- 2014-10-08 CA CA2926582A patent/CA2926582C/fr active Active
- 2014-10-08 CA CA2927951A patent/CA2927951C/en active Active
- 2014-10-08 WO PCT/EP2014/071543 patent/WO2015052237A1/fr not_active Ceased
- 2014-10-08 US US15/027,738 patent/US9821000B2/en active Active
- 2014-10-08 PL PL14781242T patent/PL3065732T3/pl unknown
- 2014-10-08 US US15/028,139 patent/US10231985B2/en active Active
- 2014-10-08 ES ES14781242.4T patent/ES2674869T3/es active Active
- 2014-10-08 BR BR112016007536-6A patent/BR112016007536B1/pt active IP Right Grant
- 2014-10-08 JP JP2016521712A patent/JP6502335B2/ja active Active
- 2014-10-08 JP JP2016521780A patent/JP6594866B2/ja active Active
- 2014-10-08 AU AU2014333636A patent/AU2014333636B2/en active Active
- 2014-10-08 CN CN201480055631.1A patent/CN105744934B/zh active Active
- 2014-10-08 EP EP14781242.4A patent/EP3065732B1/fr active Active
- 2014-10-08 ES ES14790233.2T patent/ES2682973T3/es active Active
- 2014-10-08 EP EP14790233.2A patent/EP3065733B1/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP6502335B2 (ja) | 2019-04-17 |
| ES2682973T3 (es) | 2018-09-24 |
| FR3011467B1 (fr) | 2016-02-12 |
| JP2016535727A (ja) | 2016-11-17 |
| CA2927951C (en) | 2022-08-30 |
| US20160287542A1 (en) | 2016-10-06 |
| EP3065733B1 (fr) | 2018-05-30 |
| AU2014333853A1 (en) | 2016-05-12 |
| JP6594866B2 (ja) | 2019-10-23 |
| WO2015052433A1 (fr) | 2015-04-16 |
| EP3065732B1 (fr) | 2018-04-11 |
| JP2016535725A (ja) | 2016-11-17 |
| EP3065732A1 (fr) | 2016-09-14 |
| ES2674869T3 (es) | 2018-07-04 |
| US20160256429A1 (en) | 2016-09-08 |
| BR112016007536A8 (pt) | 2018-01-30 |
| BR112016007536A2 (pt) | 2017-09-26 |
| US9821000B2 (en) | 2017-11-21 |
| CN105744934B (zh) | 2019-08-20 |
| CN105744934A (zh) | 2016-07-06 |
| AU2014333636B2 (en) | 2019-12-05 |
| CA2927951A1 (en) | 2015-04-16 |
| CN105828814B (zh) | 2019-04-19 |
| CA2926582A1 (fr) | 2015-04-16 |
| FR3011467A1 (fr) | 2015-04-10 |
| BR112016007536B1 (pt) | 2020-10-13 |
| CN105828814A (zh) | 2016-08-03 |
| US10231985B2 (en) | 2019-03-19 |
| EP3065733A1 (fr) | 2016-09-14 |
| CA2926582C (fr) | 2023-07-25 |
| AU2014333636A1 (en) | 2016-05-05 |
| WO2015052237A1 (fr) | 2015-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3065732T3 (pl) | Związki, kompozycje i odpowiednie zastosowania do zapobiegania i/lub leczenia dyslipidemii | |
| IL246252A0 (en) | Diaminopyrimidyl derivative compounds, their compositions and methods of treatment | |
| EP3068289A4 (en) | Prevention and treatment of bed exits, falls, and other conditions | |
| ZA201505011B (en) | Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith | |
| IL264446A (en) | Compounds and compositions and their use | |
| GB201423376D0 (en) | Antimicrobial compounds, compositions and methods | |
| IL242483B (en) | Preparations containing omomyc and their use for cancer treatment | |
| SG11201704628VA (en) | Macrocyclic compounds as irak1/4 inhibitors and uses thereof | |
| PT3102555T (pt) | Composições de compostos e seus usos | |
| IL247319A0 (en) | Triazine compound, preparations containing them and their uses | |
| SG10201705899XA (en) | Prevention & treatment of neuropathy | |
| IL249640A0 (en) | Preparations for the treatment of nosebleeds | |
| IL244621A0 (en) | Preparations for the treatment of hypertension and/or fibrosis | |
| IL244622A0 (en) | Preparations for the treatment of hypertension and/or fibrosis | |
| IL248783A0 (en) | Fluorescence quenching compounds, preparations containing them and their uses | |
| AP2015008338A0 (en) | Compounds for the treatment and prevention of retroviral infections | |
| PL2968478T3 (pl) | Kompozycje i sposoby do leczenia karboksyhemoglobinemii | |
| SG10202100751YA (en) | Compounds and compositions and uses thereof | |
| EP2994156A4 (en) | Compounds, compositions and methods for the treatment of diseases through inhibiting tgf- activity | |
| IL255042A0 (en) | Amphiphilic compounds, their preparations and uses | |
| EP3209667A4 (en) | Nargenicin compounds and uses thereof as antibacterial agents | |
| PL2862576T3 (pl) | Drobnoustroje i zawierające je kompozycje do stosowania do leczenia lub profilaktyki zapalenia sutka | |
| HUE040081T2 (hu) | Készítmény migrén vagy neuropátiás fájdalom kezelésére és megelõzésére | |
| GB201407759D0 (en) | Antibacterial compounds, compositions and uses thereof | |
| AU2013903592A0 (en) | Vaccines for the treatment or prevention of cancer |